Overview of Dr. Hermiston
Dr. Michelle Hermiston is a pediatric hematologist/oncologist in San Francisco, CA and is affiliated with multiple hospitals in the area, including UCSF Benioff Children's Hospital Oakland, UCSF Benioff Childrens Hospital, and Kaiser Permanente San Francisco Medical Center. She received her medical degree from Washington University in St. Louis School of Medicine and has been in practice 24 years. She is one of 19 doctors at UCSF Benioff Childrens Hospital and one of 55 doctors at UCSF Benioff Children's Hospital Oakland who specialize in Pediatric Hematology & Oncology. She has more than 50 publications and over 500 citings.
Office
505 Parnassus Ave
San Francisco, CA 94143Fax+1 415-353-2657
Education & Training
- Washington University in St. LouisMedical Scientist Training Program, 2024 - 2024
- University of California (San Francisco)Fellowship, Pediatric Hematology/Oncology, 1999 - 2002
- University of California (San Francisco)Residency, Pediatrics, 1997 - 1999
- Washington University in St. Louis School of MedicineClass of 1997
Certifications & Licensure
- CA State Medical License 1999 - 2026
- American Board of Pediatrics Pediatric Hematology-Oncology
Clinical Trials
- Intergroup Trial for Children or Adolescents With B-Cell NHL or B-AL: Evaluation of Rituximab Efficacy and Safety in High Risk Patients Start of enrollment: 2012 Jun 01
- LCH-IV, International Collaborative Treatment Protocol for Children and Adolescents With Langerhans Cell Histiocytosis Start of enrollment: 2016 Nov 02
Roles: Contact
- Chemoimmunotherapy and Allogeneic Stem Cell Transplant for NK T-cell Leukemia/Lymphoma Start of enrollment: 2019 Mar 01
Roles: Contact
- Join now to see all
Publications & Presentations
PubMed
- Cyclophosphamide and Thiotepa Increases Risk of Transplant-Associated Thrombotic Microangiopathy.Christine S Higham, Kristin A Shimano, Sandhya Kharbanda, Julia Chu, Gabriel Salinas Cisneros
Transplantation and Cellular Therapy. 2024-09-01 - Langerhans cell histiocytosis: NACHO update on progress, chaos, and opportunity on the path to rational cures.Kevin Bielamowicz, Peter Dimitrion, Oussama Abla, Simon Bomken, Patrick Campbell
Cancer. 2024-07-15 - 4 citationsHLH-like toxicities predict poor survival after the use of tisagenlecleucel in children and young adults with B-ALL.Kevin O McNerney, Stephanie J Si Lim, Kyle Ishikawa, Alexandra Dreyzin, Anant Vatsayan
Blood Advances. 2023-06-27
Press Mentions
- UCSF Benioff Children’s Hospitals Rank Among the Nation’s Best for 10 Specialties in 2020-2021 U.S. News & World ReportJune 16th, 2020
- Delivering Cellular and Gene Therapies to Patients: Solutions for Realizing the Potential of the Next Generation of MedicineApril 25th, 2020
- Physicians’ Education Resource® to Host Satellite Symposia at Annual American Society of Hematology Meeting and Exposition in OrlandoNovember 7th, 2019
- Join now to see all
Grant Support
- Interplay Of Innate And Adaptive Immunity In Lupus PathogenesisNational Institute Of Allergy And Infectious Diseases2010–2011
- Role Of CD45 In Hematopoiesis And LymphomagenesisNational Cancer Institute2003–2005
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: